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Trends in methadone-related deaths in Zurich 
 
P. J. Laberke, C. Bartsch 
 
 
Abstract 
Methadone has a long and successful history in the treatment of opioid-addiction. In recent years it has 
become popular again - as potent and inexpensive analgesic in patients with chronic pain. Since 
methadone has been used fatalities have been reported. In our study all methadone-associated deaths in 
Zurich from 1998 to 2007 were analysed. Most of the 146 detected deaths of the past ten years 
occurred during substitution programmes or illicit intake of methadone while only three of them could 
be attributed to methadone used as an analgesic. Noticeable in our study was the high percentage of 
cases of combined drug intoxication (76%). The most frequent co-intoxicants were alcohol and 
cocaine. Mortalities attributed to methadone intoxication alone were a rare finding and could only be 
detected in five cases of deceased who had received methadone maintenance treatment.  
The aim of our study is to assess the trends in the number and nature of methadone-related fatalities in 
Zurich during the last nineteen years. For this purpose a previous study from Zurich (1989-1997) was 
included, whereby a very long oberservation period and large number of cases resulted. 
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Introduction 
The opioid methadone was initially synthesized by the chemists Max Bockemühl and Gustav Erhart in 
1939 and first used as a highly potent analgesic [18]. Because of its long half-life, good enteral 
resorption and low costs it became an important substance in the treatment of opiate addiction [2, 16, 
18, 22]. This measure successfully helped to reduce mortality, criminal behaviour and the spreading of 
disease transmitted through intravenous drug use [18, 19]. Other studies showed a significant lower 
rate of additional consumption of drugs – especially of opioids – and an increase in quality of life [17, 
19]. 
Methadone maintenance treatment (MMT) for heroin-addicted persons started in the United States in 
1964 and in Europe (Uppsala, Sweden) in 1966. Maintenance programmes in Switzerland were made 
legal in 1975 and have always been using only the racemic mixture (dl-methadone). Easy access to 
substitution programmes was implemented in the canton of Zurich in 1991 [4, 15, 18]. 
Since initiation of the official statistics Swiss Health Authorities have recorded approximately 18,000 
methadone treated addicts each year. Through the whole period from 1999 to 2007 the number of 
persons enrolled in a methadone programme in Zurich also remained stable with about 3,900 
individuals per year [1]. 
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In recent years the usage of methadone as an analgesic has become more important again and a 
correlation between increased methadone distribution and a rise of methadone-associated mortality is 
seen [21]. 
Since the substance has first been used, methadone-related deaths have been reported. Several studies 
focussed on forensic autopsies in which methadone was detected in postmortem toxicology and tried 
to point out its role in drug-associated deaths [1-23].  
In the catchment area of the Institute of Legal Medicine of Zurich a large drug scene is located and one 
third of all drug deaths of Switzerland are undergoing forensic examination here. With our research we 
wanted to evaluate the changes in Zurich during the past 19 years, and also the proportion of death due 
to methadone as an analgesic. Is there still a progressive increase in death cases related to methadone? 
 
Methods 
All autopsies during a 10-year-period (n=4121), from 1998 to 2007, were retrospectively evaluated. 
Searching the keyword methadone in our archive revealed 159 cases. 
In all of the 146 included methadone related fatalities without severe decomposition a complete 
autopsy had been carried out and detailed documentation was available from which demographic data 
and the cause and manner of death could be extracted.  
Results of chemical-toxicological testings were mainly based on blood and urine samples. Only in a 
few cases toxicologic analysis were performed in organs and tissues (kidney and muscle). As part of 
routine toxicologic analysis urine drug screens were performed by immunoassay testing for EDDP (2-
ethylidene-1.5-dimethyl-3.3-diphenylpyrrolidine; CEDIA®-test), opioids, benzoylecgonine, 
cannabinoids, amphetamines, benzodiazepines and barbiturates. Whenever possible blood from the 
femoral vein was prefered and tested after extraction with solid phase extraction (SPE) by gas 
chromatography-mass spectrometry (GC-MS), quantifying methadone and illicit drugs. Alcohol-
analyses had been carried out with GC-ECD (headspace). In cases with appropriate history, 
psychotropic agents - such as antidepressants - were also included in the screening. Analysis of hair 
samples had not been performed by default.  
Unfortunately only few of our records contained full information pertaining history of drug 
consumption, especially of methadone intake, duration of a current maintenance programme, daily 
methadone dosage and circumstances of death. For this reason it wasn’t possible to appraise the 
phenomenon of drug-tolerance. The manner of death therefore could not often be clearly classified as 
a suicidal or accidental drug overdose. 
In a further step we compared our data with the data of a previous study (1989-1997) raised by 
colleagues of our Institute. 
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Results 
A total of 146 cases (3,5% of all performed autopsies) showed positive results for methadone in the 
postmortem toxicologic analysis. Fig. 1 shows the development of drug related deaths during the 
investigated time period. A progressive increase until 2006 and a sudden drop in 2007 are obvious. 
Tab. 1 provides an overview of the whole data. The individuals were predominantly male (n=102, 
70%) and ranged from 17 to 59 years (mean age 36 years). The females ranged between 17 and 61 
years (mean age 37 years). Methadone blood levels (MBL) ranged from 70 µg/L to 14,000 µg/L 
(mean 1,324 µg/L, median 700 µg/L). 
57 deceased (39%, mean age 37 years) had been enrolled in MMT (42 men and 15 women) and had 
received a methadone dosage between 20 mg and 300 mg per day. MBL ranged from 100 µg/L to 
12,000 µg/L (mean 1,574 µg/L, median 900 µg/L).  
The group of 86 individuals without MMT (59%, mean age 35 years) included 60 males and 26 
females with a daily consumption of methadone of 15 mg – 300 mg. MBL ranged from 70 µg/L to 
9,000 µg/L (mean 1,022 µg/L, median 615 µg/L).  
Three women (2%, 37, 43 and 53 years) had received methadone as an analgesic. MBL of 430 µg/L, 
1,200 µg/L and 14,000 µg/L were found. 
7,5 percent (n = 11, mean age 39 years) of mortalities were attributed to methadone intoxication alone 
(MBL: 500 µg/L to 2,500 µg/L, mean 1073 µg/L, median 850 µg/L). Five of these 11 patients (45%) - 
all females - died while receiving MMT (MBL: 650 µg/L - 1.700 µg/L, mean 1,040 µg/L, median 850 
µg/L). The group of the 6 remaining individuals who were not participating in MMT (MBL: 500 µg/L 
to 2,500 µg/L, mean 1,100 µg/L, median 780 µg/L) was predominated by males.  
Combined drug intoxication was identified in 111 of 146 individuals (76%, mean age 35) and included 
81 men (mean age 35 years) and 30 women (mean age 36 years). MBL ranged from 70 µg/L to 14,000 
µg/L (mean 1,492 µg/L, median 700 µg/L). The combination of methadone and one other substance (n 
= 49) was dominated by alcohol. The group with the combination of methadone and only 
benzodiazepines was dominated by females – all other groups of combined drug toxicity were 
predomianted by males. The combination of three to six substances was found in 62 cases.  
Just 4 of these 111 cases of combined drug intoxication could definitely be classified as a suicidal 
incident. In all of the remaining 107 individuals no further assessment could be made whether a 
suicidal or accidental intoxication was present. 
Alcohol - at the top of the list of all detected co-intoxicants - was present in 58 of all 146 cases (40%). 
Blood alcohol concentration levels (BAC) ranged between 0,02 and 4,07 g/L (mean 0,76 g/L, median 
0,32 g/L).  
Cocaine or its metabolites were detected in 55 of the 146 cases (38%) ranging from 5 µg/L to 190 
µg/L for cocaine (mean 45 µg/L, median 25 µg/L), from 6 µg/L to 1,500 µg/L for benzoylecgonine 
(mean 50 µg/L, median 110 µg/L) and from 10 µg/L to 6,000 µg/L for methylecgonine (median 1068 
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µg/L, median 535 µg/L). In 4 cases ethylecgonine was found as a marker for combined use of alcohole 
and cocaine. 18 of these 55 deceased (32%) had been in a current MMT. 
Benozodiazepines were found in 41 of 146 samples (28%), among them the most frequent were 
nordazepam, oxazepam and diazepam. In 37% (n=15) the intake was related to participation to MMT. 
Other opioids were seen in 37 of the 146 cases (25%) – morphine 5 µg/L to 5,000 µg/L (mean 517 
µg/L, median 50 µg/L), codiene 3 µg/L to 700 µg/L (mean 62 µg/L, median 15 µg/L) and 
monoacetylmorphine (6 cases) 5 µg/L to 40 µg/L (mean 17 µg/L, median 25 µg/L). 14 of these 37 
persons (38%) were enrolled in MMT. 
Psychotropic agents - mainly antidepressants - were detected in 24 of 146 samples (16%).  
Amphetamines (1%) and cannabinoids (1%) could not be detected as single-intoxicants in 
combination with methadone and played a minor role in patients with a combination of 3 or more 
substances. 
In 11 of the 146 cases (7,5%) methadone could be detected but death was attributed to natural causes 
including cardio-vascular disease (n=4), hypovolemic shock (n=3), pneumonia (n=2), insufficiency of 
the liver (n=1) and acute pancreatitis (n=1). In these cases MBL ranged from 120 µg/L to 1,200 µg/L 
(mean 529 µg/L, median 430 µg/L). 
In the 5 cases (3,4%) of non-natural death that could not be attributed to the comsuption of substances, 
we found two cases of failure of central regualtion after blunt trauma and one case each of drowning, 
hypothermia and polytrauma (MBL: 170 µg/L – 2,500 µg/L, mean 1744 µg/L, median 250 µg/L). 
In 8 of the 146 cases (5,5%) the cause of death remained unexplained despite extensive forensic 
examination. MBL ranged from 330 µg/L to 900 µg/L (mean 653 µg/L, median 620 µg/L). 
 
Discussion 
Several studies have discussed the role of drug-related deaths involving methadone. We observed an 
increase in the number of methadone-related deaths in recent years which is consitent with the findings 
of many other investigators [6, 9, 17, 18, 22]. One author however found a decrease [16] - but this 
finding may result from only a small collective.  
The total number of cases found during the investigated time periods varies a lot. These differences 
may be explained by the study’s design, regional, social and cultural factors or simply the availability 
of drugs or maintenance programmes. 
Among the long-term studies [6, 7, 8, 10] with an observation period of 10 years or more with 146 
deceased we investigated a relatively large number of cases. However, some shorter studies of five 
years in length or less presented data with an even larger number of victims [5, 18].  
The study by Hauri et al. [8] (Tab. 1) reviewed 114 methadone-associated deaths between 1989 and 
1997. 
Compared to his data our study revealed an increase of 28% of methadone-associated deaths in Zurich 
in the last 10 years, while the number of drug addicts in MMT in Zurich and Switzerland remained 
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stable [1]. We could not find a conclusion for the sudden drop in the number of fatalities in Zurich in 
2007. An increase in the proportion of men and mean age was also seen in our collective. Other 
significant differences to Hauri were a tripling of the highest MBL and a doubling of the mean MBL 
in our study while the median MBL did not differ that much (500 µg/L vs. 700 µg/L). By substantial 
changes in methodology from GC-NPD (gas chromatography-nitrogen phosphorus detector) to GC-
MS (gas chromatography-mass spectroscopy) in Zurich between 1989 and 2007 the sensitivity of 
detection increased, but the quantitative results for the therapeutical levels remained comparable. The 
number of persons in MMT did not change over the years. New findings were fatalities associated 
with methadone used as an analgesic - an observation which had also been discussed by health 
authorities in the last time [21]. According to our evaluation the total number of cases which could be 
assigned to methadone intoxication alone, natural death and non-natural death (except lethal 
intoxication) decreased. In Hauri`s collective, 64% of deaths could be attributed to combined drug 
intoxication. We found a distinct increase up to 76%. Between 1989 and 1997 in Zurich the most 
frequent additional substances used with methadone were benzodiazepines, alcohol and other opioids. 
The main co-intoxicants in our blood samples were alcohol and cocaine while the influence of 
benzodiazepines and other opioids appeared to regress. 
We showed a distinct and even increasing predominance of males among methadone-related deaths 
which is also a common finding in other studies [1, 16, 17, 19, 22]. The only exception is the study by 
Worm [23]. However she presented just a small number of cases where the data cannot be accepted as 
representative of all cases.  
The mean age in other investigations, including the studies from Zurich, ranged from the late 20´s to 
the late 30´s [15-18, 22, 23]. Our recent study however showed the mean age increase by 7 years. This 
supports findings that a mortality is reduced as a consequence of MMT [18]. 
Of note in our study were blood-concentrations of methadone with values up to 14,000 µg/L. 
Compared to the results of other authors this is more than a tripling [8, 15, 17, 18]. The existence of 
such high MBL implies a methadone-induced tolerance and enough survival-time for resorption in 
case of oral application or an intravenous application of a large dosage of methadone [14]. With regard 
to the increasing age of the deceased in our study an induction of tolerance is quite comprehensible 
and would also lead to an intake of a higher daily methadone-dosage. The comparability of the data 
from Zurich is ensured by the use of the racemic mixture from the start of MMT in Switzerland – a 
fact that was’t traceable in other studies and which may have a severe influence in the direct 
comparison of detected MBL. In our study only 8 of 146 cases showed a MBL over 4500 µg/L. This 
explains the high mean MBL of 1,324 µg/L and the “usual” median MBL of 700 µg/L. However, 
many previous investigators have also commented on the difficulty in performing post-mortem 
toxicologic analyses, interpreting the results and establishing a lethal MBL [3, 7, 12, 14, 17, 18, 22]. 
Therefore a large degree of error is possible. 
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The ratio of persons in Zurich with and without MMT has not changed in the last 20 years. Compared 
to other studies our detected rate of deceased receiving treatment (39%) is in the lower range. 
Accordingly 61% of the victims in our collective must have received their methadone illegally and 
without medical support. The apparently low acceptance of MMT in the canton of Zurich cannot be 
understood by the authors because to the easy access to substitution programmes in that area. 
Many previous studies have emphasised the frequent presence of other drugs in methadone-related 
deaths. In our study, 76% of the deceased died as a result of combined drug intoxication. A similar or 
even higher percentage of combined toxicity was seen in other studies [7, 8, 16-18, 20, 22]; however 
not all of them are representative – some sampled only a very small number of cases. The 
development in Zurich from 1989 to 2007 documents the rising problem of parallel consumption of 
several substances and an increased importance of alcohol, while the consumption of benzodiazepines 
and other opioids decreased - a finding consistent only in the study by Graß [7]. In contrast most of the 
previous studies, revealed benzodiazepines as the most frequent additional substances [8, 16, 20, 22, 
23]. According to the development in Zurich’s and Switzerland’s drug scene in recent years [13] we 
detected cocaine in second place which seemed to be of no particular relevance in other studies. 
In Dobler-Mikola’s study [4] a more frequent use of illicit drugs during MMT in Switzerland was seen 
and explained by a presumably higher activity of the drug scene. On the other hand it is possible that 
due to a higher sensitivity of the toxicological analyses more additional substances were detected.  
As aforementioned in many cases it was not possible to classify the manner of death as a suicidal or 
accidential drug overdose due to a lack of information. Only four of our 111 deceased (3,6%) had 
verifiably commited suicide with the intake of several substances while other studies showed a ratio of 
suicides close to 50% [9]. Hauri et al. [8] identified 12 cases (10,5%) of suicide in Zurich between 
1989 and 1997. 
In the last few years several case reports and studies have described the occurrence of cardiac 
arrhythmia with the use of methadone particularly with regard to prolongation of the QT-interval [2, 
11]. To determine the cause of death clearly as fatal arrhythmia it would be necessary to have very 
detailed information about the deceased - general medical anamnesis and extensive data of the current 
MMT. 
Finally, MMT, if carried out correctly, is a very useful and save tool in the treatment of heroin 
addiction. Only five deaths in our ten-year-study were attributed to methadone intoxication alone 
while receiving MMT. Compared to an average of 3,900 substituted persons in the canton of Zurich 
each year this is a very rare finding (0,1%). Furthermore the mean age in the deceased in our collective 
increased by an average of seven years (in the group of MMT by eight years) which is presumably 
another positive effect of methadone, especially in MMT. In most of our cases combined drug 
intoxication was present in terms of parallel consumption of other substances which should not occur 
according to the guidelines of MMT. Thus, a stricter control of the participants in maintenance 
treatment and additional support in cases of concomitant drug-use should be considered in the future. 
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Our study pointed out the general problem of interpretation of post mortem MBL and the retrospective 
collection of reliable data. Therefore a prospective study in close collaboration with an institution for 
substitution treatment is pursuited, with special regard to pain treatment and cardiac side effects of 
methadone.  
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Fig. 1 Methadone maintenance treatment (MMT) and methadone-related deaths in Switzerland and 
Zurich 
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Tab. 1 Changes in methadone-related deaths in Zurich from 1989-2007 
(MBL = Methadone blood level, MMT = Methadone maintenance treatment)   
 Zurich 
1989-1997 
Zurich 
1998-2007 
Cases [n] 114 146 
Males [%] 61 70 
Females [%] 39 30 
Mean age [years] 29 36 
MBL-range [µg/L] 30-4,500 70-14,000 
Mean MBL [µg/L] 730 1,324 
Median MBL [µg/L] 500 700 
MMT [%] 39 39 
Methadone as analgesic [%] 0 2 
Methadone  
mono-intoxication [%] 
10,5 7,5 
Combined intoxication [%] 64 76 
Natural death [%] 9,7 7,5 
Non-natural death (except 
intoxication) [%] 
15,8 3,4 
Unclear death [%] 0 5,5 
 
